Volume: 3, Issue: 1
ABSTRACT
Rare diseases present significant challenges in healthcare due to their diverse symptoms, limited scientific understanding, and inadequate treatment options. Moebius Syndrome and Hutchinson- Gilford Progeria Syndrome (HGPS) are two such rare conditions that illustrate the complexities and impact of these disorders. Moebius Syndrome, characterized by facial and ocular nerve paralysis, poses challenges in diagnosis and management due to its genetic and environmental origins. Similarly, HGPS, a genetic disorder causing premature aging symptoms, underscores the urgent need for effective treatments. Despite their rarity, these diseases profoundly impact patients' quality of life, emphasizing the importance of heightened awareness, research collaboration and equitable access to healthcare. Additionally, involving affected individuals in clinical trials can improve research investigations and